These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10348753

  • 1. OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa.
    Danel F, Hall LM, Duke B, Gur D, Livermore DM.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1362-6. PubMed ID: 10348753
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F, Hall LM, Gur D, Livermore DM.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490
    [Abstract] [Full Text] [Related]

  • 4. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Hall LM, Livermore DM, Gur D, Akova M, Akalin HE.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
    [Abstract] [Full Text] [Related]

  • 5. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [Abstract] [Full Text] [Related]

  • 6. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
    Poirel L, Girlich D, Naas T, Nordmann P.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739
    [Abstract] [Full Text] [Related]

  • 7. Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro.
    Mugnier P, Casin I, Bouthors AT, Collatz E.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3113-6. PubMed ID: 9835500
    [Abstract] [Full Text] [Related]

  • 8. Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.
    Danel F, Hall LM, Livermore DM.
    J Antimicrob Chemother; 1999 Mar; 43(3):339-44. PubMed ID: 10223588
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 10. OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginosa.
    Aubert D, Poirel L, Ali AB, Goldstein FW, Nordmann P.
    J Antimicrob Chemother; 2001 Nov; 48(5):717-21. PubMed ID: 11679562
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D, Colomb M, Dehecq B, Belmonte O, Courvalin P, Plésiat P, Meziane-Cherif D.
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [Abstract] [Full Text] [Related]

  • 12. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
    Krasauskas R, Labeikytė D, Markuckas A, Povilonis J, Armalytė J, Plančiūnienė R, Kavaliauskas P, Sužiedėlienė E.
    Ann Clin Microbiol Antimicrob; 2015 Nov 26; 14():52. PubMed ID: 26611758
    [Abstract] [Full Text] [Related]

  • 13. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H, Altındiş M, Aşık G, Demir C.
    Mikrobiyol Bul; 2015 Apr 26; 49(2):156-65. PubMed ID: 26167816
    [Abstract] [Full Text] [Related]

  • 14. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Danel F, Hall LM, Gur D, Livermore DM.
    Antimicrob Agents Chemother; 1995 Aug 26; 39(8):1881-4. PubMed ID: 7486940
    [Abstract] [Full Text] [Related]

  • 15. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C, Ferreira E, Correia JD, Gonçalves J, Caniça M.
    J Antimicrob Chemother; 2002 Jan 26; 49(1):77-85. PubMed ID: 11751770
    [Abstract] [Full Text] [Related]

  • 16. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.
    Danel F, Hall LM, Gur D, Akalin HE, Livermore DM.
    J Antimicrob Chemother; 1995 Feb 26; 35(2):281-94. PubMed ID: 7759392
    [Abstract] [Full Text] [Related]

  • 17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z, Satana D, Kayacan C, Can B, Gönüllü N, Küçükbasmacı O.
    Mikrobiyol Bul; 2012 Jul 26; 46(3):386-97. PubMed ID: 22951651
    [Abstract] [Full Text] [Related]

  • 18. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
    Ullah W, Qasim M, Rahman H, Khan S, Rehman ZU, Ali N, Muhammad N.
    Microb Pathog; 2017 Apr 26; 105():240-244. PubMed ID: 28258003
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.
    Mushtaq S, Warner M, Livermore DM.
    J Antimicrob Chemother; 2010 Nov 26; 65(11):2376-81. PubMed ID: 20801783
    [Abstract] [Full Text] [Related]

  • 20. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
    Qing Y, Cao KY, Fang ZL, Huang YM, Zhang XF, Tian GB, Huang X.
    J Med Microbiol; 2014 Mar 26; 63(Pt 3):386-392. PubMed ID: 24398232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.